How Donald Trump’s executive order on drug prices could hit Indian research companies
The order, which calls for a policy under which the US would pay the ‘most-favoured-nation’ price – essentially the lowest price that other comparable countries pay for certain drugs – is expected to hit innovator companies rather than those that make cheap generic drugs. Innovators will look at ways to reduce costs, so the amount…